title: Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice.
abstract: Nestin regulatory-element-driven green fluorescent protein (ND-GFP) transgenic mice highly express GFP in proliferating endothelial cells and nascent blood vessels. In the present study, we visualized angiogenesis in experimental lung and liver metastases by GFP imaging in the ND-GFP transgenic mice. The murine melanoma cell line, B16F10 expressing red fluorescent protein (RFP), was injected i.v. in ND-GFP mice. ND-GFP was highly expressed in proliferating nascent blood vessels in the tumors that developed in the lung after tail vein injection, and in the tumors that developed in the liver after portal vein injection of RFP-expressing melanoma cells. Liver metastasis and angiogenesis were imaged intravitally. Doxorubicin significantly decreased metastatic angiogenesis in the liver. These results demonstrate a new imageable model of angiogenesis in metastasis in the liver and the lung. This new model should enable further understanding of the onset of angiogenesis in metastasis and its effect on metastatic growth. The model will serve as a unique screen for inhibitors of angiogenesis of metastatic tumors. The fact that liver-metastasis angiogenesis can be imaged in the live animal enables real-time studies of the effect of angiogenesis inhibitors.
authors.affiliation: AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Amoh
authors.forename: Michael
authors.initials: M
authors.lastname: Bouvet
authors.forename: Lingna
authors.initials: L
authors.lastname: Li
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Tsuji
authors.forename: A R
authors.initials: AR
authors.lastname: Moossa
authors.forename: Kensei
authors.initials: K
authors.lastname: Katsuoka
authors.forename: Robert M
authors.initials: RM
authors.lastname: Hoffman
mesh_terms: D000818:Animals; D004317:Doxorubicin / Q000494:pharmacology; D049452:Green Fluorescent Proteins; D007150:Immunohistochemistry; D007381:Intermediate Filament Proteins; D008114:Liver Neoplasms, Experimental / Q000098:blood supply* / Q000556:secondary; D008175:Lung Neoplasms / Q000098:blood supply* / Q000556:secondary; D051379:Mice; D008822:Mice, Transgenic; D009389:Neovascularization, Pathologic / Q000175:diagnosis*; D009419:Nerve Tissue Proteins; D064231:Nestin; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000032:analysis
chemical_list: D007381:Intermediate Filament Proteins; D009419:Nerve Tissue Proteins; C577485:Nes protein, mouse; D064231:Nestin; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D049452:Green Fluorescent Proteins; D004317:Doxorubicin